ISO 13485:2003
As of April 8, 2008, we are certified according to ISO 13485:2003.
SGS DNA now offers state-of-the-art mass spectrometry as an additional means of QC analysis.
Mass determination confirms the correct molecular weight of the manufactured oligonucleotide.
The cGMP compliant and validated method uses Electrospray Ionization Time-of-Flight Mass Spectrometry (ESI-TOF MS), performed for all types of oligonucleotides. The mass determination features an accuracy of +/- 3 daltons from the theoretical molecular weight for oligonucleotides up to about 80 nucleotides in length.
Sequence determination confirms that the correct sequence was manufactured.
The sequence of the oligonucleotide is determined by using exonuclease digestion in combination with Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS). Sequence determination can be performed for unmodified oligonucleotides up to about 45 nucleotides in length.
July 2004
Patrick De Meyer, Director of International Marketing, will give a lecture on "Oligonucleotides for the Molecular Diagnostics Industry" on the SMi conference Market Opportunities & Technology Trends in Molecular Diagnostics, London, UK,
November 3-4
May 2004
SGS DNA will be present during the Euro-TIDES meeting in Brussels, Belgium, November 16-17. Stand number 7.
March 2004
SGS DNA will participate in the ASHG-meeting in Toronto, Canada, October 27-29.
Our booth number is 617.
January 2004
SGS DNA expands its current facilities in Köping with 200 m2 to increase its capacity in processing and purification. This brings the total number of dedicated clean room areas for handling large scale oligonucleotides to 16.
Meanwhile, the start of the building of a new facility in Arboga has been postponed until 2005-2006.
December 2003
SGS DNA has been certified to comply with the ISO 9001:2000 quality management system requirements.
